review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Robert Young | Q124161902 |
P2093 | author name string | Raewyn J Hopkins | |
P2860 | cites work | Lung cancer susceptibility model based on age, family history and genetic variants | Q21091204 |
Genome-wide association study identifies five loci associated with lung function | Q24629653 | ||
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function | Q24633262 | ||
Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study | Q24644661 | ||
The basics of epithelial-mesenchymal transition | Q24652992 | ||
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies | Q24653818 | ||
Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function | Q24681700 | ||
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland | Q28140600 | ||
A short history of lung cancer | Q28199299 | ||
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers | Q28259916 | ||
Survival of patients with stage I lung cancer detected on CT screening | Q28270460 | ||
E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases | Q28385103 | ||
Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD | Q28743099 | ||
Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research | Q28754732 | ||
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 | Q28943480 | ||
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease | Q29614871 | ||
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 | Q29614944 | ||
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study | Q29614971 | ||
Genetics and pulmonary medicine.10: Genetic epidemiology of pulmonary function | Q30496386 | ||
Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up | Q30806378 | ||
International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways | Q30850865 | ||
Framingham Heart Study genome-wide association: results for pulmonary function measures | Q33300819 | ||
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. | Q33419815 | ||
A genome-wide association study of pulmonary function measures in the Framingham Heart Study | Q33419839 | ||
The COPD genetic association compendium: a comprehensive online database of COPD genetic associations | Q33559787 | ||
Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care | Q33794627 | ||
Smoking and lung cancer: the role of inflammation | Q33842487 | ||
Developing COPD: a 25 year follow up study of the general population | Q34577485 | ||
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history | Q34604212 | ||
Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease | Q35694443 | ||
Inducible innate resistance of lung epithelium to infection | Q35754472 | ||
Genetics of COPD. | Q35770021 | ||
Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland | Q35906553 | ||
Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease | Q36248645 | ||
Epithelial-mesenchymal transition in lung cancer: is tobacco the "smoking gun"? | Q36399326 | ||
Rho GTPase activating proteins in cancer phenotypes | Q36570345 | ||
State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer | Q36571997 | ||
The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? | Q36863297 | ||
Genome-wide association studies provide new insights into type 2 diabetes aetiology | Q36912145 | ||
Association of radiographic emphysema and airflow obstruction with lung cancer | Q36915507 | ||
Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes | Q36955879 | ||
Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis | Q37083161 | ||
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics | Q37106945 | ||
Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease | Q37111384 | ||
Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease | Q37149401 | ||
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. | Q37178709 | ||
Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA | Q37211163 | ||
Current concepts on the role of inflammation in COPD and lung cancer | Q37316084 | ||
Systemic manifestations and comorbidities of COPD. | Q37465879 | ||
Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer | Q37471392 | ||
Immunologic aspects of chronic obstructive pulmonary disease | Q37506948 | ||
Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research | Q37553688 | ||
Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence | Q37562594 | ||
Smoking cessation: the potential role of risk assessment tools as motivational triggers | Q37672052 | ||
Mechanisms involved in lung cancer development in COPD. | Q37800575 | ||
Pharmacological actions of statins: potential utility in COPD. | Q37801150 | ||
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. | Q37834029 | ||
Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer | Q38296825 | ||
Lung cancer detection in patients with airflow obstruction identified in a primary care outpatient practice | Q38474511 | ||
Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults | Q39296602 | ||
A common familial component in lung cancer and chronic obstructive pulmonary disease | Q39598779 | ||
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. | Q39955550 | ||
Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling | Q40098558 | ||
Inhibitory effect of statins on renal epithelial-to-mesenchymal transition | Q40250501 | ||
Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. | Q40442526 | ||
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer | Q40664922 | ||
Airways obstruction and the risk for lung cancer | Q41481140 | ||
Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. | Q42474300 | ||
Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition | Q42919170 | ||
Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk | Q42952638 | ||
The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort | Q44934998 | ||
Lung cancer gene associated with COPD: triple whammy or possible confounding effect? | Q46269161 | ||
Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. | Q51898509 | ||
Requirement for Rac1 in a K-ras induced lung cancer in the mouse. | Q53329326 | ||
Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. | Q54599241 | ||
P433 | issue | 7 | |
P921 | main subject | lung cancer | Q47912 |
P304 | page(s) | 1047-1055 | |
P577 | publication date | 2011-10-01 | |
P1433 | published in | Respirology | Q15753093 |
P1476 | title | How the genetics of lung cancer may overlap with COPD. | |
P478 | volume | 16 |
Q55106203 | Analysis of the Clinicopathological Characteristics and Risk Factors in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease. |
Q36540914 | Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium |
Q36112558 | Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer |
Q34840130 | Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era |
Q26786812 | COPD and its comorbidities: Impact, measurement and mechanisms |
Q58572012 | Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer |
Q47564926 | Chronic obstructive pulmonary disease among lung cancer-free smokers: The importance of healthy controls |
Q34031235 | Chronic obstructive pulmonary disease as a risk factor for lung cancer |
Q55354282 | Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer. |
Q41604995 | Circulating tumor cell interactions with macrophages: implications for biology and treatment |
Q36320998 | Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease |
Q36695396 | Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer |
Q36878756 | IL-17 induces EMT via Stat3 in lung adenocarcinoma |
Q55005225 | Low diffusing capacity, emphysema, or pulmonary fibrosis: who is truly pulling the lung cancer strings? |
Q88310782 | Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology |
Q99565824 | Lung cancer and obstructive lung disease in never smokers |
Q38195806 | Lung carcinogenesis from chronic obstructive pulmonary disease: characteristics of lung cancer from COPD and contribution of signal transducers and lung stem cells in the inflammatory microenvironment |
Q34507403 | Macrophages facilitate coal tar pitch extract-induced tumorigenic transformation of human bronchial epithelial cells mediated by NF-κB. |
Q50905501 | Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. |
Q52722348 | Prognostic significance of CT-determined emphysema in patients with small cell lung cancer. |
Q39000705 | Rare variant of MAP2K7 is associated with increased risk of COPD in southern and eastern Chinese |
Q33558881 | Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease |
Q37689941 | Smoking exposure, loss of forced expiratory volume in one second and the risk of lung cancer among patients with malignant disease who present with cardiac or pulmonary symptoms: a cross-sectional study |
Q38569752 | Smoking, inflammation and small cell lung cancer: recent developments |
Q34089332 | State-of-the-art MS technology applications in lung disease. |
Q37644907 | Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study. |
Q41679073 | The Functional Copy Number Variation-67048 in WWOX Contributes to Increased Risk of COPD in Southern and Eastern Chinese |
Q92653813 | The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly |
Q34656726 | Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities. |
Q37976117 | Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer |
Q88585706 | [Clinical characteristics and risk factors affecting outcomes of elderly patients with non-small cell lung cancer complicated by chronic obstructive pulmonary disease] |
Search more.